Shi, X., Zhou, J., Qian, C., Gao, L., Wang, B., & Feng, X. (2020). Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports. Onco Targets Ther.

Shi, Xuefei, Jia Zhou, Caihua Qian, Liliang Gao, Bin Wang, و Xueren Feng. "Radiofrequency Ablation With Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports." Onco Targets Ther 2020.

Shi, Xuefei, et al. "Radiofrequency Ablation With Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports." Onco Targets Ther 2020.